Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic InterStim

This article was originally published in The Gray Sheet

Executive Summary

Firm submits a PMA application for treatment of fecal incontinence with the neurostimulation implant, anticipating a U.S. launch in 2009, Medtronic announces Oct. 22. The device, which works by stimulating the sacral nerve, has been approved since 2006 for urinary incontinence (1"The Gray Sheet" July 10, 2006, In Brief)
Advertisement

Related Content

Correction on Medtronic’s InterStim neurostimulator
Medtronic urology approval
Advertisement
UsernamePublicRestriction

Register

MT026721

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel